Tuberculosis Prevention in the Private Sector: Using Claims-Based Methods to Identify and Evaluate Latent Tuberculosis Infection Treatment With Isoniazid Among the Commercially Insured

Journal of Public Health Management and Practice : JPHMP
Erica L StockbridgeChristine Ho

Abstract

Targeted identification and treatment of people with latent tuberculosis infection (LTBI) are key components of the US tuberculosis elimination strategy. Because of recent policy changes, some LTBI treatment may shift from public health departments to the private sector. To (1) develop methodology to estimate initiation and completion of treatment with isoniazid for LTBI using claims data, and (2) estimate treatment completion rates for isoniazid regimens from commercial insurance claims. Medical and pharmacy claims data representing insurance-paid services rendered and prescriptions filled between January 2011 and March 2015 were analyzed. Four million commercially insured individuals 0 to 64 years of age. Six-month and 9-month treatment completion rates for isoniazid LTBI regimens. There was an annual isoniazid LTBI treatment initiation rate of 12.5/100 000 insured persons. Of 1074 unique courses of treatment with isoniazid for which treatment completion could be assessed, almost half (46.3%; confidence interval, 43.3-49.3) completed 6 or more months of therapy. Of those, approximately half (48.9%; confidence interval, 44.5-53.3) completed 9 months or more. Claims data can be used to identify and evaluate LTBI treatment with ...Continue Reading

References

Oct 6, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S A GilroyD C Blair
Mar 29, 2001·Annual Review of Public Health·B A Virnig, M McBean
May 15, 2003·American Journal of Respiratory and Critical Care Medicine·Philip A LoBue, Kathleen S Moser
Sep 24, 2005·Health Services Research·Kimberly J O'MalleyCarol M Ashton
Jan 21, 2006·American Journal of Respiratory and Critical Care Medicine·Timothy R SterlingUNKNOWN Tuberculosis Epidemiologic Studies Cosortium
Jun 15, 2006·The Journal of Infection·Armen E ParsyanC Robert Horsburgh
Feb 6, 2007·American Journal of Respiratory and Critical Care Medicine·David E GriffithUNKNOWN Infectious Disease Society of America
Jul 13, 2007·The European Respiratory Journal·T W RennieI P Bates
Jul 24, 2008·JAMA : the Journal of the American Medical Association·Kevin P CainWilliam R Mac Kenzie
Jun 25, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Heather YoungJennifer S Daly
Oct 2, 2009·Chest·C Robert HorsburghUNKNOWN Tuberculosis Epidemiologic Studies Consortium
Jan 12, 2011·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Benjamin M SmithDick Menzies
Jun 24, 2011·Current Drug Abuse Reviews·Maria StefanidouChara A Spiliopoulou
Aug 16, 2011·British Journal of Nursing : BJN·Nigel ClerkGeorge Antunes
Nov 30, 2013·International Journal of Clinical Pharmacy·Brandy McGinnisMarsha A Raebel
Jan 1, 2016·MMWR. Morbidity and Mortality Weekly Report·Kai H YoungJohn Jereb
Feb 13, 2016·American Journal of Respiratory and Critical Care Medicine·James D MancusoTzu-Cheg Kao
Mar 10, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ruth N MoroStefan V Goldberg
Mar 25, 2016·MMWR. Morbidity and Mortality Weekly Report·Jorge L SalinasAdam J Langer
Apr 16, 2016·PloS One·Courtney M YuenAnne Marie France
May 18, 2016·BMC Infectious Diseases·Andreas SandgrenMarieke J van der Werf
Sep 7, 2016·JAMA : the Journal of the American Medical Association·UNKNOWN US Preventive Services Task ForceMichael P Pignone
Oct 27, 2016·JAMA : the Journal of the American Medical Association·Kirsten Bibbins-Domingo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.